Displaying drugs 13651 - 13675 of 13829 in total
BMS-564929
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Matched Iupac: … 4-[(7R,7aS)-7-hydroxy-1,3-dioxo-hexahydro-1H-pyrrolo[1,2-c]imidazol-2-yl]-2-chloro-3-methylbenzonitrile …
Matched Description: … So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause. …
Matched Description: … So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause. …
TBX-3400
TBX-3400 is an investigational cell-based immunotherapy consisting of autologous peripheral blood mononuclear cells (PBMCs) treated ex vivo with TBX-4000, which is a recombinant TAT-MYC fusion protein.[L44281,L44286]
Investigational
Matched Description: … TBX-3400 is an investigational cell-based immunotherapy consisting of autologous peripheral blood mononuclear …
DCVAC/OvCa
DCVAC/OvCa is a therapy comprising autologous dendritic cells pulsed with killed ovarian cancer cells and matured by TLR3 ligand ex vivo. It is under investigation for the treatment of ovarian cancer.
Investigational
Matched Description: … It is under investigation for the treatment of ovarian cancer. …
ARO-APOC3
ARO-APOC3 is an investigational RNAi therapeutic targeting apolipoprotein C-III (APOC3). It received an Orphan Drug designation by the FDA for the treatment of familial chylomicronemia syndrome.
Investigational
Matched Description: … It received an Orphan Drug designation by the FDA for the treatment of familial chylomicronemia syndrome …
Formononetin
Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.).
Investigational
Matched Description: … Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Carnosine
Carnosine has been investigated for the treatment of Gulf War Illness.
Investigational
Matched Iupac: … (2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid …
Matched Description: … Carnosine has been investigated for the treatment of Gulf War Illness. …
Matched Salts cas: … 5852-98-2 …
Matched Description: … Carnosine has been investigated for the treatment of Gulf War Illness. …
Matched Salts cas: … 5852-98-2 …
Vistusertib
Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
Investigational
Matched Description: … Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma. …
Vosaroxin
Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute.
Investigational
Matched Iupac: … 7-[(3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine …
Matched Description: … Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Vanutide cridificar
Vanutide cridificar has been investigated for the treatment of Alzheimer Disease.
Investigational
Matched Description: … Vanutide cridificar has been investigated for the treatment of Alzheimer Disease. …
Dalcetrapib
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
Matched Iupac: … 1-(2-ethylbutyl)-N-{2-[(2-methylpropanoyl)sulfanyl]phenyl}cyclohexane-1-carboxamide …
Matched Description: … Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome. …
Matched Description: … Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome. …
Tavilermide
Tavilermide has been investigated for the treatment of Dry Eye Syndromes.
Investigational
Matched Description: … Tavilermide has been investigated for the treatment of Dry Eye Syndromes. …
Belotecan
Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.
Investigational
Matched Iupac: … (19S)-19-ethyl-19-hydroxy-10-{2-[(propan-2-yl)amino]ethyl}-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11 ... }.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione …
Matched Description: … Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer. …
Matched Description: … Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer. …
PF-00446687
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
Pilsicainide
Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.
Investigational
Matched Iupac: … N-(2,6-dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide …
Matched Description: … Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation. …
Matched Salts cas: … 88069-49-2 …
Matched Description: … Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation. …
Matched Salts cas: … 88069-49-2 …
GET-73
Get 73 has been investigated for the treatment of Alcohol Dependence.
Investigational
Matched Description: … Get 73 has been investigated for the treatment of Alcohol Dependence. …
Pentavalent Antimony
Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.
Investigational
Matched Description: … Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis. …
beta-Apopicropodophyllin
beta-Apopicropodophyllin is a component of the freshwater plant Micranthemum umbrosum.
Experimental
Matched Description: … beta-Apopicropodophyllin is a component of the freshwater plant _Micranthemum umbrosum_. …
Dilanubicel
Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells.
Investigational
Matched Description: … Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells. …
Diminazene
Diminazene, also known as Diminazine, 4,4'-(Diazoamino)benzamidine, 4,4'-(1-triazene-1,3-diyl)bis-benzenecarboximidamide, diminazine aceturate, or Diminazene aceturate, is a trypanocidal agent. Major brands of Diminazene are Berenil, Pirocide, Ganasag, and Azidin. This substance is a solid. This compound belongs to the phenylhydrazines. These are compounds containing a phenylhydrazide moiety, which consists of a hydrazide substituent...
Experimental
Matched Iupac: … 4-[(2E)-3-(4-carbamimidoylphenyl)triaz-2-en-1-yl]benzene-1-carboximidamide …
Matched Description: … Major brands of Diminazene are Berenil, Pirocide, Ganasag, and Azidin. This substance is a solid. ... These are compounds containing a phenylhydrazide moiety, which consists of a hydrazide substituent attached ... Known drug targets of diminazene include HTH-type transcriptional regulator QacR, trypsin-1, amiloride-sensitive …
Matched Description: … Major brands of Diminazene are Berenil, Pirocide, Ganasag, and Azidin. This substance is a solid. ... These are compounds containing a phenylhydrazide moiety, which consists of a hydrazide substituent attached ... Known drug targets of diminazene include HTH-type transcriptional regulator QacR, trypsin-1, amiloride-sensitive …
Nalorphine
Nalorphine is a mixed opioid agonist–antagonist. It acts at two opioid receptors—at the mu receptor it has antagonistic effects, and at the kappa receptors it exerts high-efficacy agonistic characteristics. It is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid dependence.
Experimental
Vet approved
Matched Iupac: … (1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca …
Matched Description: … It is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid …
Matched Description: … It is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid …
MT-0169
MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to a human single chain variable fragment with affinity for human CD38 cell surface protein.
Investigational
Matched Description: … MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to …
Nisoxetine
Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. It was originally investigated as an antidepressant but has no current clinical applications aside from being a research standard SNRI. It has been used to research obesity and energy balance, and exerts some local analgesia effects.
Experimental
Matched Iupac: … [3-(2-methoxyphenoxy)-3-phenylpropyl](methyl)amine …
Matched Description: … Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. …
Matched Description: … Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. …
Onfekafusp alfa
Onfekafusp alfa is under investigation in clinical trial NCT02938299 (Neoadjuvant L19IL2/L19TNF- Pivotal Study).
Investigational
Matched Description: … Onfekafusp alfa is under investigation in clinical trial NCT02938299 (Neoadjuvant L19IL2/L19TNF- Pivotal …
alpha-methylthiofentanyl
alpha-methylthiofentanyl is an opioid analgesic that is an analog of fentanyl.
Illicit
Matched Iupac: … N-phenyl-N-{1-[1-(thiophen-2-yl)propan-2-yl]piperidin-4-yl}propanamide …
Matched Description: … alpha-methylthiofentanyl is an opioid analgesic that is an analog of fentanyl. …
Matched Description: … alpha-methylthiofentanyl is an opioid analgesic that is an analog of fentanyl. …
Cadaverine
Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine.
Experimental
Matched Description: … Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine. …
Displaying drugs 13651 - 13675 of 13829 in total